Which has the lower trailing P/E, ABBV or PFE?

PFE has the lower trailing P/E: ABBV trades at 72.43 and PFE at 36.63. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ABBV or PFE?

Over the past five years, PFE grew revenue faster — ABBV at a 3.69% CAGR versus PFE at 6.29%.

Does ABBV or PFE pay a bigger dividend?

ABBV yields 2.68% and PFE yields 6.19% based on trailing dividends and the latest price.

Is ABBV or PFE more profitable?

ABBV runs the higher net margin — ABBV at 9.81% versus PFE at 6.81%.

How have ABBV and PFE total returns compared?

Over the past 10 years, ABBV delivered 19.76% and PFE delivered 3.17% annualized total return. Past performance doesn't predict future results.

AbbVie Inc. (ABBV) vs Pfizer Inc. (PFE)

A side-by-side comparison of AbbVie Inc. and Pfizer Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.

ABBV

AbbVie Inc.

$454.17B

$257.06HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

PFE

Pfizer Inc.

$157.99B

$27.72HealthcareDelayed quote: Sep 11, 2026, 4:01 PM EDT

Total return — ABBV vs PFE

growth of $100 · dividends reinvested · last 10y

ABBV +497.3% (+19.6%/yr)PFE +34.0% (+3.0%/yr)ABBV compounded faster over this window

ABBV PFE

ABBV vs PFE: by the numbers

•ABBV is the larger company ($454.17B vs $157.99B market cap).
•PFE trades at the lower trailing earnings multiple (36.63 vs 72.43 P/E), one valuation lens rather than an overall verdict.
•ABBV converts more revenue to profit (9.81% vs 6.81% net margin).
•PFE grew revenue faster over the past five years (6.29% vs 3.69% CAGR).
•PFE pays the higher dividend yield (6.19% vs 2.68%).

Metrics side by side

Valuation

Metric	ABBV	PFE
P/E ratio	72.43	36.63
Forward P/E	18.32	9.32
P/S ratio	7.05	2.48
P/B ratio	N/A	1.85
EV / EBITDA	19.34	10.15
FCF yield	3.99%	6.95%

Profitability

Metric	ABBV	PFE
Gross margin	71.48%	71.32%
Operating margin	29.32%	25.08%
Net margin	9.81%	6.81%
ROE	N/A	5.09%
ROIC	13.46%	9.33%

Dividends

Metric	ABBV	PFE
Dividend yield	2.68%	6.19%
Payout ratio	192.43%	227.27%

Growth (annualized)

Metric	ABBV	PFE
Revenue CAGR (5Y)	3.69%	6.29%
EPS CAGR (5Y)	-2.79%	-3.78%
FCF CAGR (5Y)	0.11%	-3.11%
Total return CAGR (5Y)	23.51%	-4.68%

Frequently asked

Which has the lower trailing P/E, ABBV or PFE?: PFE has the lower trailing P/E: ABBV trades at 72.43 and PFE at 36.63. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ABBV or PFE?: Over the past five years, PFE grew revenue faster — ABBV at a 3.69% CAGR versus PFE at 6.29%.
Does ABBV or PFE pay a bigger dividend?: ABBV yields 2.68% and PFE yields 6.19% based on trailing dividends and the latest price.
Is ABBV or PFE more profitable?: ABBV runs the higher net margin — ABBV at 9.81% versus PFE at 6.81%.
How have ABBV and PFE total returns compared?: Over the past 10 years, ABBV delivered 19.76% and PFE delivered 3.17% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ABBV analysis Full PFE analysis Interactive comparison tool

Dig into the metrics

AbbVie P/E ratio Pfizer P/E ratio AbbVie dividend yield Pfizer dividend yield AbbVie ROE Pfizer ROE AbbVie operating margin Pfizer operating margin AbbVie revenue growth Pfizer revenue growth AbbVie free cash flow Pfizer free cash flow

AbbVie & Pfizer appear in these rankings

Highest Dividend Yield Stocks 25+ Year Dividend Growers Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.